Home › Funds › Parkman Healthcare Partners LLC › SYK
Parkman Healthcare Partners LLC position in SYK
STRYKER CORPORATION · Health Care
Parkman Healthcare Partners LLC reported holding 67,973 shares of SYK (STRYKER CORPORATION) in its Q2 2026 13F filing — a position valued at US$21.4M, representing 2.19% of its reported portfolio and ranking #14 among its reported holdings. Parkman Healthcare Partners LLC has disclosed SYK holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's SYK position evolved
Parkman Healthcare Partners LLC first disclosed a stake in SYK in Q3 2024 at 28,000 shares (US$10.1M). The position peaked in Q1 2026 at 154,771 shares, worth US$50.9M. Across 8 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 67,973 shares valued at US$21.4M — a reduction of -86,798 shares quarter over quarter.. Notable position changes include a 178% increase in Q4 2024 (shares rose 3% over the following quarter), a 65% increase in Q4 2025 (shares fell 7% over the following quarter), a 56% trim in Q2 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 28.00K | $10.12M | New |
| Q4 2024 | 77.72K | $27.98M | Add |
| Q1 2025 | 77.69K | $28.92M | Hold |
| Q2 2025 | 50.38K | $19.93M | Reduce |
| Q3 2025 | 64.11K | $23.70M | Add |
| Q4 2025 | 105.47K | $37.07M | Add |
| Q1 2026 | 154.77K | $50.86M | Add |
| Q2 2026 | 67.97K | $21.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SYK and 13F data
SYK (STRYKER CORPORATION) is a Health Care company. 25 other funds we track also report a position in SYK — the largest reported positions include JPMorgan Chase & Co (US$5.71B), GREENLEAF TRUST (US$4.79B), PRICE T ROWE ASSOCIATES INC /MD/ (US$3.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SYK
- JPMorgan Chase & Co 17.26M sh · $5.71B · Q2 2026
- GREENLEAF TRUST 15.23M sh · $4.79B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.92M sh · $3.75B · Q2 2026
- Wellington Management Group 8.17M sh · $2.57B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 8.17M sh · $2.57B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 4.93M sh · $1.62B · Q2 2026
- Arrowstreet Capital 3.28M sh · $1.03B · Q2 2026
- First Western Trust Bank 3.02M sh · $949.98M · Q2 2026
- Fundsmith LLP 2.91M sh · $917.39M · Q2 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held SYK?
Parkman Healthcare Partners LLC has disclosed SYK holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Parkman Healthcare Partners LLC's current position in SYK?
As of Q2 2026, Parkman Healthcare Partners LLC holds 67.97K shares of SYK (STRYKER CORPORATION), valued at $21.40M, representing 2.19% of its reported portfolio and ranking #14.
Has Parkman Healthcare Partners LLC been buying or selling SYK?
In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC reduced its position in SYK. The position peaked in Q1 2026 at 154.77K shares.
Which other funds hold SYK?
Other major institutional holders of SYK include JPMorgan Chase & Co, GREENLEAF TRUST, PRICE T ROWE ASSOCIATES INC /MD/, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.